Pre-Open Stock Movers 3/21: (ECYT) (UPIP) (LIN) Higher; (ISR) (AIR) (SONS) Lower (more...)
Tweet Send to a Friend
Endocyte (NASDAQ: ECYT) 145.8% HIGHER; results from the Phase 2b TARGET trial, which showed that the study met the primary ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
